FDA Peptide Update: Category 2 Removals Explained FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 # FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions